‘A sign of trust, not weakness': One thing you need to talk to your partner about today
It's one of the most important relationships — if not the most important — we have in our lives. But one major barrier is holding Australians back from having an equally important conversation with their partner — and it could to be their detriment.
Though almost one in two (49 per cent) people speak to their loved one about their mental health at least once a week — and one in five (19 per cent) do so every day, research by News Corp's Growth Distillery with Medibank found that one in three Australians across all generations don't talk about it at all, out of fear of becoming a burden to their significant other. A further one in four said they were afraid of being misunderstood, dismissed or perceived as weak.
Georgia Grace is a certified sex and relationship practitioner, somatic therapist and author based in Sydney.
'We need to get better at treating mental health disclosures as a sign of trust, not weakness,' she said.
'If you want intimacy — emotional, sexual, or otherwise — you have to make space for the imperfect stuff. That's where real connection happens.'
Australia is in the grips of a mental health crisis, and people are struggling to know who to turn to, especially our younger generations. Can We Talk? is a News Corp awareness campaign, in partnership with Medibank, equipping Aussies with the skills needed to have the most important conversation of their life.
Fear of being a burden or misunderstood aren't the only barriers holding Australians back from confiding in their partner about their mental health, Grace said. Another key driver is fear of losing the relationship itself, 'especially if in the past they have tried to ask for help or express they weren't OK and they were ignored or punished'. Indeed, one in four respondents shared that they were afraid of negative repercussions.
One in two Australians speak to their partner about their mental health at least once a week, new research has found. Picture: David Swift
'Shame may also be getting in the way — a lot of people still carry the belief that struggling mentally makes them weak, broken or unlovable,' she said.
'So instead of opening up, they hide it, and that can become its own kind of pain. It might also be the fact that they don't know how to talk about their emotions, or they don't have the language to express what they're feeling. Many of us haven't been given the tools, so it can feel easier to let it go unsaid.'
'Hiding often does the most damage'
Linda Williams is a senior psychologist and clinical lead at digital youth mental organisation ReachOut. Given your partner 'is one of the closest people to you, in most cases, they'll be able to tell something is wrong', she said. Of Australians' relationships, an overwhelming 81 per cent of respondents said that the one had the most trust in is the one they share with their partner, followed by close friends (75 per cent), parents (73 per cent) and children (71 per cent).
'It can be hard watching someone you love struggle, and not knowing why or how you can help,' Ms Williams said.
'If you don't open up about your experiences, you risk misunderstandings. They might feel like you don't trust them, which can put strain on your relationship.'
Grace agreed. 'Hiding often does the most damage. When you're not talking about what's going on, the relationship starts running on assumptions, silence, and second-guessing,' she said.
'Your partner might start thinking you're pulling away, not interested, or emotionally unavailable when really, you're just trying to survive. That disconnect can create tension, resentment, or emotional shutdown.
Believing that you always have to be 'the strong one' and that no one ever helps you can become a self-fulfilling prophecy,' Grace warned. 'If you never ask for help or never share what you're feeling … our partners aren't mind-readers.'
'You don't have to tell them everything at once'
There is no 'right' time to disclose a mental health problem you might have with your partner — 'no perfect milestone or script'. But, Grace said, 'sooner is usually better, especially if it's starting to affect how you show up in the relationship'.
'It's probably best not to 'unload' on a first date. Being open about your mental health is important, however, be intentional with what you share, as it can feel really overwhelming for your date if they feel like they need to go into 'therapist mode',' she advised.
When you do decide to broach the conversation, it can be helpful to 'think of a few key things you want to share'.
'But you don't need to over-rehearse — you're allowed to be clunky,' Grace said.
Senior psychologist and clinical lead at ReachOut, Linda Williams. Picture: Supplied
Sex and relationships therapist Georgia Grace. Picture: Richard Dobson
'You don't have to tell them everything at once. Start small: (you could say) 'I've been dealing with something lately that I want share with you',' she continued.
'Be clear on what you need from them — is it support, space, or just someone to listen? You also may not know just yet and that's OK, but it'll be important to reflect on this and give them information when you're ready. (And) expect that they might not respond perfectly. That's not a sign to shut down, as they also may not have the right tools. It's a starting point for deeper understanding.'
Whether you've been together three months or 30 years, time and place is key to an effective chat.
'Choose a moment when you both have time and aren't distracted, not when you're both racing out the door on the way to work,' Grace said.
'In longer-term relationships, it's also important to discuss mental health before you feel like it's about to explode. If you trust the person and want something real with them, it's worth talking about.'
'You can't pour from an empty cup'
As for what to do if you're the one being confided in, 'listen more than you speak', Grace said.
'Don't try to fix it, because you probably can't. Also, your partner isn't a problem that needs to be fixed — they are a person in the process of living,' she added.
'Don't minimise it. Don't jump into problem-solving mode unless they ask for it. Say something like, 'Thanks for telling me. I'm here, even if I don't have the perfect words.'
'And check in again later, not just once. That's how you show someone you're in it with them.'
As the listener, Ms Williams noted that 'you might feel powerless to help, and that's OK'.
'But you can help them manage their day-to-day experiences, encourage them to get professional support and help them feel less alone,' she said.
'Looking after yourself is an important part of looking after someone else. You can't pour from an empty cup. Talking to someone you can trust can take some of the pressure off and help you navigate this tough time.'
Originally published as 'A sign of trust, not weakness': One thing you need to talk to your partner about today
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
West Australian
22 minutes ago
- West Australian
Australian news and politics live: Independent MP Chaney to introduce Bill to ban AI child sexual abuse apps
Scroll down for the latest news and updates. Independent MP Kate Chaney will today introduce a bill to outlaw technology that assists in the creation of child sexual abuse material. Under the bill it would be an offence to posess AI tools designed for the sole purpose of creating child sexual abuse material. 'This is a clear gap in our Criminal Code that I think we need to be able to respond quickly on so we can make sure we're keeping kids safe,' she said on ABC. 'Currently, possession of these images is illegal, but it's not illegal to possess these particular types of AI tools that are designed for the sole purpose of creating child sexual abuse material. 'So, it means that perpetrators can generate the material using images of real children, delete the images, and then recreate them whenever they want and avoid detection. 'This bill is focused on making it illegal to download these tools that are designed to create this material.' Ms Chaney said action was needed now. 'The challenge that we have is that we're creating a lot of reports and consultations, and the technology is moving so fast, so I think there's a need for urgent action on this. 'We need to be able to plug the gaps as we go, while addressing the broad issues about how we're going to encourage take-up of AI for its productivity benefits but creating appropriate guardrails so that people can have faith in it.'. Australians will pay no more than $25 for selected medicines for the first time in more than 20 years under a proposal to be brought before parliament. It will be the second cap on medicines on the Pharmaceutical Benefits Scheme (PBS) introduced by the Albanese government in three years, after it cut the maximum price of PBS prescriptions from $42.50 to $30. 'The size of your bank balance shouldn't determine the quality of your health care,' Prime Minister Anthony Albanese said. 'My government will continue to deliver cost-of-living relief for all Australians.' PBS medicines would be capped at $7.70 for pensioners and concession card holders until 2030. The bill's introduction is largely a formality, with its passage through the lower house all but assured thanks to Labor's massive 94-seat majority in the 150-seat House of Representatives. Read the story West is best again in economic circles but big gains made on the other side of the Nullarbor have surprised economists and left eastern states languishing. A boost in housing construction has propelled South Australia to second position, above Queensland and Victoria, in CommSec's latest State of the States report released on Monday. Western Australia remains the nation's top performer for the fourth straight quarter with strong returns on retail spending and business investment, but an upheaval could be on the horizon. 'We are seeing Western Australia lose a little bit of momentum,' CommSec chief economist Ryan Felsman told AAP. 'It's been growing at a breakneck speed the last two or three years, and the reason for that is population growth has been the highest for some time.' Read the story A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns. Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800. But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics. Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed. 'This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable',' Mr Butler said in a statement. 'For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient.'
The Advertiser
3 hours ago
- The Advertiser
Bulk bill incentive could miss thousands of GP clinics
A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns. Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800. But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics. Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed. "This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement. "For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient." From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness. The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution. "The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said. It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change. Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said. The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none. A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns. Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800. But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics. Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed. "This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement. "For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient." From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness. The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution. "The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said. It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change. Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said. The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none. A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns. Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800. But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics. Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed. "This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement. "For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient." From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness. The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution. "The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said. It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change. Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said. The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none. A plan to boost the number of fully bulk-billing general practice clinics is likely to fall dramatically short of forecasts, a healthcare directory operator warns. Labor's $7.9 billion plan to expand the Bulk Billing Incentive Program to include non-concession patients projected the number of fully bulk-billing GP clinics to rise to 4800. But healthcare directory operator Cleanbill estimates the number of entirely bulk-billing clinics will rise by just 740 to 2081 because incentive payments will not cover consultation costs for certain clinics. Federal Health Minister Mark Butler slammed the report as inaccurate and fundamentally flawed. "This is a headline-grabbing phone poll conducted by a private company whose own website says their data is not 'reliable, accurate, complete or suitable'," Mr Butler said in a statement. "For the first time, Labor will expand bulk-billing incentives to all Australians and create an additional new incentive payment for practices that bulk bill every patient." From November 1, clinics that bulk bill every patient will receive a 12.5 per cent payment for each consultation, along with a conditional, variable payment depending on the clinic's remoteness. The report found it would only make sense for clinics to accept the Bulk Billing Incentive if their out-of-pocket costs were lower than the national average, or if they were more remote and attracted a higher incentive contribution. "The vast majority (72 per cent) of GP clinics are located in metro areas, where the New Total Medicare Payment is still $16 below the current average total cost of a non-bulk-billed standard consultation," the Cleanbill report said. It estimated the economic effect of the Bulk Billing Incentive expansion would need to be between 20 per cent and 30 per cent greater than the actual amount of the incentive payment for 4800 clinics to become fully bulk-billing as a result of the change. Patients whose clinics did not switch to fully bulk billing would face higher out-of-pocket costs in future, Cleanbill said. The federal health department said the report was based on a false assumption that if a GP did not bulk bill every patient, they bulk billed none.
The Advertiser
3 hours ago
- The Advertiser
Hepatitis C is curable. Why are Australians still dying from it?
Every so often, a medical breakthrough reshapes the health landscape and offers new hope. The cure for hepatitis C is one such medical breakthrough - as significant as the discovery of penicillin. It has saved millions around the world from developing severe liver disease and liver cancer by curing their hepatitis C. It is the first ever drug to cure a virus and completely cure a chronic disease, and has been declared an "essential medicine" by the World Health Organisation. It forms the backbone of treatments offered to people living with hepatitis C in Australia today - a painless cure of one tablet per day for up to 12 weeks. It's a simple molecule that blocks the virus from replicating and is very effective, has minimal side effects, and is vastly superior to previous treatments like interferon. Since it became available under the Pharmaceutical Benefits Scheme in 2016, 62.9 per cent of all people living in Australia with hepatitis C have received the cure. Yet despite this, about 70,000 Australians still live with hepatitis C. Why, in a country with universal health care and a commitment to disease elimination, are so many people still being left behind? New analysis done by Hepatitis Australia shows that 84 per cent of people now living with hepatitis C no longer inject drugs or contracted the virus in other ways: through blood transfusions before blood screening was introduced in 1990; unsafe tattooing; or medical and dental procedures overseas in countries with less rigorous infection control. In Australia, hepatitis C has primarily been associated with injecting drug use. Significant progress has been made in working with people who inject drugs through community-led outreach, peer programs, and harm reduction services like needle and syringe exchanges. With almost 30 per cent of the prison population injecting while they are incarcerated, prisons are the primary sites of transmission for hepatitis C. Our analysis shows that in NSW, 40 per cent of all hepatitis C retreatments are delivered in prisons, and needle exchange programs are needed to prevent transmission and reinfection. Australia's response to viral hepatitis needs to adapt to the changing nature of the population. While people who inject drugs must always be a priority in our work to eliminate viral hepatitis, a new focus is needed on the many people who might not realise they live with hepatitis C or were told in the past that there was nothing they could do about it. This population is unlikely to be engaged with hepatitis programs offered through drug and alcohol, prisons and homelessness services. And so they go undiagnosed, untreated, and remain at risk of developing serious liver disease. Community hepatitis organisations create stigma-free pathways for people to seek testing and treatment for hepatitis C. When we look at the demographics of this "missing group" of about 59,000 people, they are on average aged 40 to 65, are predominantly male and might have injected drugs, even just once, in their youth or had a tattoo overseas. The research tells us they are hesitant to talk about their life experiences with their regular GP, and this is where community outreach services, like those offered by community hepatitis organisations, become incredibly important. Hepatitis C is a ticking time bomb that slowly damages and inflames the liver, leading to serious liver disease and, potentially, cancer if left untreated. Most people have no symptoms of hepatitis C for many years until their liver is seriously affected. No one should die from a curable disease because of stigma, silence or a missed opportunity. Australia has what it takes to eliminate hepatitis C. We must act with urgency and compassion to make sure no one is left behind. It can be hard to take the first step to getting cured for hepatitis C. That's why we launched HepLink with funding from the Australian government Department of Health, Disability and Ageing, a free, confidential service that helps people find hepatitis-friendly doctors in their area - no Medicare card required. If you think you could be at risk or if you tested positive a long time ago and didn't realise there was a simple cure, call HepLink on 1800 437 222 or visit for free, confidential information and support. Every so often, a medical breakthrough reshapes the health landscape and offers new hope. The cure for hepatitis C is one such medical breakthrough - as significant as the discovery of penicillin. It has saved millions around the world from developing severe liver disease and liver cancer by curing their hepatitis C. It is the first ever drug to cure a virus and completely cure a chronic disease, and has been declared an "essential medicine" by the World Health Organisation. It forms the backbone of treatments offered to people living with hepatitis C in Australia today - a painless cure of one tablet per day for up to 12 weeks. It's a simple molecule that blocks the virus from replicating and is very effective, has minimal side effects, and is vastly superior to previous treatments like interferon. Since it became available under the Pharmaceutical Benefits Scheme in 2016, 62.9 per cent of all people living in Australia with hepatitis C have received the cure. Yet despite this, about 70,000 Australians still live with hepatitis C. Why, in a country with universal health care and a commitment to disease elimination, are so many people still being left behind? New analysis done by Hepatitis Australia shows that 84 per cent of people now living with hepatitis C no longer inject drugs or contracted the virus in other ways: through blood transfusions before blood screening was introduced in 1990; unsafe tattooing; or medical and dental procedures overseas in countries with less rigorous infection control. In Australia, hepatitis C has primarily been associated with injecting drug use. Significant progress has been made in working with people who inject drugs through community-led outreach, peer programs, and harm reduction services like needle and syringe exchanges. With almost 30 per cent of the prison population injecting while they are incarcerated, prisons are the primary sites of transmission for hepatitis C. Our analysis shows that in NSW, 40 per cent of all hepatitis C retreatments are delivered in prisons, and needle exchange programs are needed to prevent transmission and reinfection. Australia's response to viral hepatitis needs to adapt to the changing nature of the population. While people who inject drugs must always be a priority in our work to eliminate viral hepatitis, a new focus is needed on the many people who might not realise they live with hepatitis C or were told in the past that there was nothing they could do about it. This population is unlikely to be engaged with hepatitis programs offered through drug and alcohol, prisons and homelessness services. And so they go undiagnosed, untreated, and remain at risk of developing serious liver disease. Community hepatitis organisations create stigma-free pathways for people to seek testing and treatment for hepatitis C. When we look at the demographics of this "missing group" of about 59,000 people, they are on average aged 40 to 65, are predominantly male and might have injected drugs, even just once, in their youth or had a tattoo overseas. The research tells us they are hesitant to talk about their life experiences with their regular GP, and this is where community outreach services, like those offered by community hepatitis organisations, become incredibly important. Hepatitis C is a ticking time bomb that slowly damages and inflames the liver, leading to serious liver disease and, potentially, cancer if left untreated. Most people have no symptoms of hepatitis C for many years until their liver is seriously affected. No one should die from a curable disease because of stigma, silence or a missed opportunity. Australia has what it takes to eliminate hepatitis C. We must act with urgency and compassion to make sure no one is left behind. It can be hard to take the first step to getting cured for hepatitis C. That's why we launched HepLink with funding from the Australian government Department of Health, Disability and Ageing, a free, confidential service that helps people find hepatitis-friendly doctors in their area - no Medicare card required. If you think you could be at risk or if you tested positive a long time ago and didn't realise there was a simple cure, call HepLink on 1800 437 222 or visit for free, confidential information and support. Every so often, a medical breakthrough reshapes the health landscape and offers new hope. The cure for hepatitis C is one such medical breakthrough - as significant as the discovery of penicillin. It has saved millions around the world from developing severe liver disease and liver cancer by curing their hepatitis C. It is the first ever drug to cure a virus and completely cure a chronic disease, and has been declared an "essential medicine" by the World Health Organisation. It forms the backbone of treatments offered to people living with hepatitis C in Australia today - a painless cure of one tablet per day for up to 12 weeks. It's a simple molecule that blocks the virus from replicating and is very effective, has minimal side effects, and is vastly superior to previous treatments like interferon. Since it became available under the Pharmaceutical Benefits Scheme in 2016, 62.9 per cent of all people living in Australia with hepatitis C have received the cure. Yet despite this, about 70,000 Australians still live with hepatitis C. Why, in a country with universal health care and a commitment to disease elimination, are so many people still being left behind? New analysis done by Hepatitis Australia shows that 84 per cent of people now living with hepatitis C no longer inject drugs or contracted the virus in other ways: through blood transfusions before blood screening was introduced in 1990; unsafe tattooing; or medical and dental procedures overseas in countries with less rigorous infection control. In Australia, hepatitis C has primarily been associated with injecting drug use. Significant progress has been made in working with people who inject drugs through community-led outreach, peer programs, and harm reduction services like needle and syringe exchanges. With almost 30 per cent of the prison population injecting while they are incarcerated, prisons are the primary sites of transmission for hepatitis C. Our analysis shows that in NSW, 40 per cent of all hepatitis C retreatments are delivered in prisons, and needle exchange programs are needed to prevent transmission and reinfection. Australia's response to viral hepatitis needs to adapt to the changing nature of the population. While people who inject drugs must always be a priority in our work to eliminate viral hepatitis, a new focus is needed on the many people who might not realise they live with hepatitis C or were told in the past that there was nothing they could do about it. This population is unlikely to be engaged with hepatitis programs offered through drug and alcohol, prisons and homelessness services. And so they go undiagnosed, untreated, and remain at risk of developing serious liver disease. Community hepatitis organisations create stigma-free pathways for people to seek testing and treatment for hepatitis C. When we look at the demographics of this "missing group" of about 59,000 people, they are on average aged 40 to 65, are predominantly male and might have injected drugs, even just once, in their youth or had a tattoo overseas. The research tells us they are hesitant to talk about their life experiences with their regular GP, and this is where community outreach services, like those offered by community hepatitis organisations, become incredibly important. Hepatitis C is a ticking time bomb that slowly damages and inflames the liver, leading to serious liver disease and, potentially, cancer if left untreated. Most people have no symptoms of hepatitis C for many years until their liver is seriously affected. No one should die from a curable disease because of stigma, silence or a missed opportunity. Australia has what it takes to eliminate hepatitis C. We must act with urgency and compassion to make sure no one is left behind. It can be hard to take the first step to getting cured for hepatitis C. That's why we launched HepLink with funding from the Australian government Department of Health, Disability and Ageing, a free, confidential service that helps people find hepatitis-friendly doctors in their area - no Medicare card required. If you think you could be at risk or if you tested positive a long time ago and didn't realise there was a simple cure, call HepLink on 1800 437 222 or visit for free, confidential information and support. Every so often, a medical breakthrough reshapes the health landscape and offers new hope. The cure for hepatitis C is one such medical breakthrough - as significant as the discovery of penicillin. It has saved millions around the world from developing severe liver disease and liver cancer by curing their hepatitis C. It is the first ever drug to cure a virus and completely cure a chronic disease, and has been declared an "essential medicine" by the World Health Organisation. It forms the backbone of treatments offered to people living with hepatitis C in Australia today - a painless cure of one tablet per day for up to 12 weeks. It's a simple molecule that blocks the virus from replicating and is very effective, has minimal side effects, and is vastly superior to previous treatments like interferon. Since it became available under the Pharmaceutical Benefits Scheme in 2016, 62.9 per cent of all people living in Australia with hepatitis C have received the cure. Yet despite this, about 70,000 Australians still live with hepatitis C. Why, in a country with universal health care and a commitment to disease elimination, are so many people still being left behind? New analysis done by Hepatitis Australia shows that 84 per cent of people now living with hepatitis C no longer inject drugs or contracted the virus in other ways: through blood transfusions before blood screening was introduced in 1990; unsafe tattooing; or medical and dental procedures overseas in countries with less rigorous infection control. In Australia, hepatitis C has primarily been associated with injecting drug use. Significant progress has been made in working with people who inject drugs through community-led outreach, peer programs, and harm reduction services like needle and syringe exchanges. With almost 30 per cent of the prison population injecting while they are incarcerated, prisons are the primary sites of transmission for hepatitis C. Our analysis shows that in NSW, 40 per cent of all hepatitis C retreatments are delivered in prisons, and needle exchange programs are needed to prevent transmission and reinfection. Australia's response to viral hepatitis needs to adapt to the changing nature of the population. While people who inject drugs must always be a priority in our work to eliminate viral hepatitis, a new focus is needed on the many people who might not realise they live with hepatitis C or were told in the past that there was nothing they could do about it. This population is unlikely to be engaged with hepatitis programs offered through drug and alcohol, prisons and homelessness services. And so they go undiagnosed, untreated, and remain at risk of developing serious liver disease. Community hepatitis organisations create stigma-free pathways for people to seek testing and treatment for hepatitis C. When we look at the demographics of this "missing group" of about 59,000 people, they are on average aged 40 to 65, are predominantly male and might have injected drugs, even just once, in their youth or had a tattoo overseas. The research tells us they are hesitant to talk about their life experiences with their regular GP, and this is where community outreach services, like those offered by community hepatitis organisations, become incredibly important. Hepatitis C is a ticking time bomb that slowly damages and inflames the liver, leading to serious liver disease and, potentially, cancer if left untreated. Most people have no symptoms of hepatitis C for many years until their liver is seriously affected. No one should die from a curable disease because of stigma, silence or a missed opportunity. Australia has what it takes to eliminate hepatitis C. We must act with urgency and compassion to make sure no one is left behind. It can be hard to take the first step to getting cured for hepatitis C. That's why we launched HepLink with funding from the Australian government Department of Health, Disability and Ageing, a free, confidential service that helps people find hepatitis-friendly doctors in their area - no Medicare card required. If you think you could be at risk or if you tested positive a long time ago and didn't realise there was a simple cure, call HepLink on 1800 437 222 or visit for free, confidential information and support.
